Baldwin Investment Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,435
Closed -$423K 257
2021
Q3
$423K Buy
4,435
+1,035
+30% +$109K 0.07% 172
2021
Q2
$423K Buy
3,400
+1,700
+100% +$203K 0.07% 173
2021
Q1
$224K Buy
1,700
+100
+6% +$13.7K 0.04% 227
2020
Q4
$212K Buy
+1,600
New +$193K 0.04% 225

Other funds holding EXAS

Baldwin Investment Management's EXAS Position: Q4 2021 in Review

Baldwin Investment Management sold out of Exact Sciences (EXAS) in Q4 2021, closing a stake of 4,435 shares — an estimated $423K sold.

Baldwin Investment Management first reported a position in EXAS in Q4 2020 and held it in 4 quarters. The position peaked at $423K in Q3 2021. 596 funds tracked by Wall St. Rank hold EXAS as of Q4 2021.

  • Baldwin Investment Management reported no remaining Exact Sciences position as of Q4 2021 after selling out during the quarter.
  • Baldwin Investment Management sold 4,435 Exact Sciences shares in Q4 2021, an estimated $423K.
  • Baldwin Investment Management first reported a position in Exact Sciences in Q4 2020 and held it in 4 quarters.
  • Baldwin Investment Management's Exact Sciences position peaked at $423K in Q3 2021.
  • 596 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2021.

Based on Baldwin Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.